Elabscience

CLPTM1L Polyclonal Antibody

Product Code:
 
E-AB-13157
Product Group:
 
Primary Antibodies
Supplier:
 
Elabscience
Host Type:
 
Rabbit
Antibody Isotype:
 
IgG
Antibody Clonality:
 
Polyclonal
Regulatory Status:
 
RUO
Target Species:
 
Human
Applications:
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Immunohistochemistry (IHC)
Shipping:
 
Ice packs
Storage:
 
-20°C
1 / 2
Immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using CLPTM1L Polyclonal Antibody at dilution 1:60
2 / 2
Immunohistochemistry of paraffin-embedded Human liver cancer tissue using CLPTM1L Polyclonal Antibody at dilution 1:60
❮❯

Immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using CLPTM1L Polyclonal Antibody at dilution 1:60
Immunohistochemistry of paraffin-embedded Human liver cancer tissue using CLPTM1L Polyclonal Antibody at dilution 1:60

No additional charges, what you see is what you pay! *

CodeSizePrice
E-AB-13157-20uL20uL£125.00
Quantity:
E-AB-13157-60uL60uL£172.00
Quantity:
E-AB-13157-120uL120uL£237.00
Quantity:
E-AB-13157-200uL200uL£344.00
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: China.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • Show All

Further Information

Abbreviation:
CLPTM1L
Background:
Cleft lip and palate transmembrane protein 1-like protein(CLPTM1-like protein), also known ascisplatin resistance-related protein 9(CRR9p), is aproteinthat in humans is encoded by theCLPTM1Lgene.CRR9p is associated withcisplatin-inducedapoptosis.CLPTM1L, which lies within a cancer susceptibility locus on chromosome 5 (5p15.33), has been found to be commonly over-expressed in lung tumors and to confer resistance to apoptosis caused by genotoxic agents in association with up-regulation of the anti-apoptotic protein, Bcl-xL.
Buffer:
PBS with 0.05% sodium azide and 50% glycerol, PH7.4
Concentration:
1.2 mg/mL
Conjugation:
Unconjugated
Dilution:
IHC 1:50-1:200
Immunogen:
Synthetic peptide of human CLPTM1L
Purification method:
Affinity purification
Target Synonym:
C130052I12Rik;Cisplatin resistance related protein 9;Cisplatin resistance related protein CRR9p;Cisplatin resistance-related protein 9;Cleft lip and palate transmembrane protein 1 like protein;Cleft lip and palate transmembrane protein 1-like protein;CLP1L;CLPTM1 like;CLPTM1 like protein;CLPTM1-like protein;CLPTM1L;CRR9;CRR9p;DKFZp666M1010;DKFZp761M2324;FLJ14400;FLJ32533;MGC36304;OTTHUMP00000220655;RGD1307896
UNIProt ID:
Q96KA5

Documents